Allianz, Brokers

Allianz Brokers Split on Valuation Even as Targets Drift Higher

Published on 11/19/2026 at 21:21 | Editorial boerse-global.de
AlphaValue/Baader lifted its Allianz target to 521 euros and Jefferies to 470, but both kept cautious ratings, seeing shares as fairly to fully valued.
Allianz, Brokers, Split, Valuation, Even, Targets, Drift, Higher, AlphaValueBaader, Jefferies Illustration mit AI erstellt.

Two European research houses have nudged their price targets for Allianz higher, yet neither is telling clients to pile in. AlphaValue/Baader Europe lifted its objective from 505 to 521 euros while keeping its reduce recommendation, and Jefferies raised its own from 440 to 470 euros on an unchanged hold rating. The gap between the two targets is wide, but the message from both is broadly the same: the shares look fairly to fully valued.

That the new AlphaValue/Baader target sits above the market price — 456.30 euros at the time of the note — does not translate into a friendlier stance. Investors reading only the headline number would miss the fact that the recommendation stayed put. Jefferies, whose target is lower, is not markedly more bearish on the stock itself, which underlines how differently the two houses frame the same company.

A core holding, but little near-term upside

For Jefferies analyst Philip Kett, Allianz works best as a dependable building block in a continental European portfolio rather than a source of imminent share-price gains. The broker sees limited room for further appreciation in the short run. It flags large-loss events, dislocations in credit markets and weaker net inflows in asset management as the main risks to that view.

At the bottom of the range, one target of 385 euros sits below the current share price. That call rests on expected earnings growth of 7 to 8 percent, a narrower valuation discount to the broader market and intensifying competition. So both ends of the spectrum counsel caution, even though their targets fall on opposite sides of today's quote.

Should investors sell immediately? Or is it worth buying Allianz?

Earnings momentum versus the valuation question

The operational picture that landed on 12 November was mixed at the headline level. Attributable net profit for the third quarter of 2026 came in at EUR 2.78 billion, down from EUR 2.85 billion a year earlier. The underlying business told a different story: operating profit climbed 6.2 percent to EUR 4.7 billion in the quarter.

Across the first nine months of 2026, operating profit reached EUR 14.1 billion — a record, and 7.8 percent above the prior-year period. On the strength of that, the insurer raised the upper end of its full-year 2026 operating guidance to around EUR 18.6 billion, up from an earlier indication of EUR 17.4 billion with a margin of plus or minus EUR 1 billion.

The shares were trading 0.5 percent lower at EUR 458.00 in the session, below Jefferies's freshly raised target. That earnings growth is real progress, but it does not settle the valuation debate on which the analysts remain divided.

Allianz at a turning point? This analysis reveals what investors need to know now.

What to watch next

Fourth-quarter 2026 figures are due on 24 February 2027 and will give investors the next read on whether profit growth is holding up. Until then, the higher AlphaValue/Baader objective amounts to a target increase without an upgrade — a distinction that matters more than the number itself.

Ad

Allianz Stock: New Analysis - 19 November

Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Allianz analysis...

Disclaimer...
en | DE0008404005 | ALLIANZ | boerse | 70537945 |